The leading manufacturer of insulin have contacted us to re-assure ABCD and our members that there is no need for public to stockpile insulin, or other diabetes medications, or technologies. This will could potentially can cause shortage and therefore put patients at risk. All pharmacies have been asked not to support or allow any stockpiling during this crisis. Please see the statement from Novo Nordisk and the statement from Sanofi.
Date of Announcement:
Image: Dr. Dinesh Nagi
Consultant in Diabetes & Endocrinology
